Plasma values of oxidants and antioxidants in acute brain hemorrhage: Role of free radicals in the development of brain injury

Biological Trace Element Research

Volumn 108, Issue 1-3, 2005, Pages 43-52

  Aygul, Recep ^a   Demircan, Berna ^a   Erdem, Fuat ^a   Ulvi, Hizir ^a   Yildirim, Abdulkadir ^a   Demirbas, Fatih ^b  

^a ATATÜRK UNIVERSITY   (Turkey)

^b Public Health Central Laboratories   (Turkey)

Author keywords

Antioxidant enzymes; Brain hemorrhage; Lipid peroxidation; Malondialdehyde; Nitric oxide; Oxidative brain injury; Reactive oxygen species; Xanthine oxidase

Indexed keywords

GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; NITRIC OXIDE; SCAVENGER; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; BRAIN HEMORRHAGE; BRAIN INJURY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GLASGOW COMA SCALE; HUMAN; LETHALITY; MALE; SCORING SYSTEM; STROKE;

EID: 28644439529     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/bter:108:1-3:043     Document Type: Article

References (43)

1. K. Butcher and J. Laidlaw, Current intracerebral haemorrhage management, J. Clin. Neurosci. 10(2), 158-167 (2003).
2. C. L. Sudlow and C. P. Warlow, Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration, Stroke 28, 491-499 (1997).
3. A. D. Mendelow, R. Bullock, G. M. Teasdale, et al., Intracranial haemorrhage induced at arterial pressure in the rat: II. Short term changes in local cerebral blood flow measured by autoradiography, Neurol. Res. 6, 189-193 (1984).
4. G. Y. Yang, A. L. Betz, T. L. Chenevert, et al., Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats, J. Neurosurg. 81, 93-102 (1994).
5. R. Bullock, J. Brock-Utne, J. van Dellen, et al., Intracerebral hemorrhage in a primate model: effect on regional cerebral blood flow, Surg. Neurol. 29, 101-107 (1998).
6. B. D. Watson, Evaluation of concomitance of lipid peroxidation in experimental models of cerebral ischemia and stroke, Prog. Brain Res. 96, 69-95 (1993).
7. M. Chopp, P. H. Chan, C. Y. Hsu, et al., DNA damage and repair in central nervous system injury, Stroke 27, 363-369 (1996).
8. S. Love, Oxidative stress in brain ischaemia, Brain Pathol. 9, 119-131 (1999).
9. J. M. Braughler, L. A. Duncan, and R. L. Chase, The involvement of iron in lipid peroxidation, J. Biol. Chem. 261, 10,282-10,289 (1986).
10. B. N. Ames, M. T. Shigenega, and M. Hagen, Oxidants, antioxidants and the degenerative diseases of aging, Proc. Natl. Acad. Sci. USA 90, 7915-7922 (1993).
11. B. Halliwell, Reactive oxygen species and the central nervous system, J. Neurochem. 59, 1609-1623 (1992).
12. J. Wu, Y. Hua, R. F. Keep, et al., Iron and iron-handling proteins in the brain after intracerebral hemorrhage, Stroke 34, 2964 (2003).
13. P. H. Chan, Role of oxidants in ischemic brain damage, Stroke 27, 1124-1129 (1996).
14. G. Teasdale and B. Jenett, Assessment of coma and impaired consciousness: a practical scale, Lancet 2, 81-83 (1974).
15. B. Jenett and M. Bond, Assessment of outcome after severe brain damage: a practical scale, Lancet 1, 480-484 (1975).
16. I. Durak, O. Canpolat, M. Kacmaz, et al., Antioxidant interferences in superoxide dismutase activity methods using superoxide radical as substrate, Clin. Chem. Lab. Med. 36, 407 (1998).
17. H. Aebi, Catalase, in Methods of Enzymatic Analysis, H. U. Bergmeyer, ed., Verlag Chemie, Weinheim, pp. 673-678 (1974).
18. D. E. Paglia and W. N. Valentina, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase, J. Lab. Clin. Med. 70, 158-169 (1967).
19. R. E. Pinto and W. Bartley, The effect of age and sex on glutathione reductase and glutathione peroxidase activities and on aerobic glutathione oxidation in rat liver homogenates, Biochem. J. 112, 109-115 (1969).
20. S. Hashimato, A new spectrophotometric assay method of xanthine oxidase in crude tissue homogenate, Anal. Biochem. 62, 425-435 (1974).
21. M. I. S. Hunter, B. C. Nlemadim, and D. L. W. Davidson, Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients, Neurochem. Res. 10, 1645-1652 (1985).
22. H. Moshage, B. Kok, J. R. Huizenga, et al., Nitrite and nitrate determinations in plasma: a critical evaluation, Clin. Chem. 41, 892-896 (1995).
23. P. N. Bories and C. Bories, Nitrate determination in biological fluids by an enzymatic one step assay with nitrate reductase, Clin. Chem. 41, 904-907 (1995).
24. H. H. Chen and J. F. Zhou, Low cholesterol in erythrocyte membranes and high lipoperoxides in erythrocytes are the potential risk factors for cerebral hemorrhagic stroke in human. Biomed. Environ. Sci. 14(3), 189-198 (2001).
25. M. B. Plotnikov, A. A. Lobanov, and V. V. Ivanov, Activation of lipid peroxidation in the brain in cerebral hemorrhage, Bull. Eksp. Biol. Med. 105(6), 677-678 (1988).
26. J. Wu, Y. Hua, R. F. Keep, et al., Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage, Brain Res. 953(1-2), 45-52 (2002).
27. M. C. Polidori, P. Mecocci, and B. Frei, Plasma vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head trauma, Stroke 32, 898-905 (2001).
28. K. Sudha, A. V. Rao, S. Rao, et al., Lipid peroxidation, hemolysis and antioxidant enzymes of erythrocytes in stroke, Indian J. Physiol. Pharmacol. 48(2), 199-205 (2004).
29. R. A. F. Felberg, J. C. Grotta, A. L. Shirzadi, et al., Cell death in experimental intracerebral hemorrhage: the "black hole" model of hemorrhagic damage, Ann. Neurol. 51(4), 517-524 (2002).
30. J. Peeling, H. J. Yan, S. G. Chen, et al., Protective effects of free radical inhibitors in intracerebral hemorrhage in rat, Brain Res. 795(1-2), 63-70 (1998).
31. J. Peeling, M. R. Del Bigio, D. Corbett, et al., Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke, Neuropharmacology 40(3), 433-439 (2001).
32. D. Mantle, S. Siddique, F. Eddeb, et al., Comparison of protein carbonyl and antioxidant levels in brain tissue from intracerebral haemorrhage and control cases, Clin. Chim. Acta 312(1-2), 185-190 (2001).
33. D. S. Warner, H. Sheng, and I. B. Haberle, Oxidants, antioxidants and the ischemic brain, J. Exp. Biol. 207, 3221-3231 (2004).
34. F. J. Romero, F. Bosch-Morell, M. J. Romero, et al., Lipid peroxidation products and antioxidants in human disease, Environ. Health Perspect. 106, 1229-1234 (1998).
35. C. Iadecola, Bright and dark sides of nitric oxide in ischemic brain injury, Trends Neurosci. 20, 132-139 (1997).
36. J. Castillo, R. Rama, and A. Dávalos, Nitric oxide-related brain damage in acute ischemic stroke, Stroke 31, 852-858 (2000).
37. C. P. Cano, V. P. Bermudez, H. E. Atencio, et al., Increased serum malondialdehyde and decreased nitric oxide within 24 hours of thrombotic stroke onset, Am. J. Ther. 10(6), 473-476 (2003).
38. X. Jin, H. Zhao, J. F. Wang, et al., Influence of beta-endorphin on function of immune system of patients with cerebral hemorrhage, Zhonghua Yi Xue Za Zhi 83(16), 1409-1442 (2003).
39. O. D. Saugstad, Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury, Pediatrics 98, 103-107 (1996).
40. A. L. Betz, Identification of hypoxanthine transport and xanthine oxydase activity in brain capillaries, J. Neurochem. 44, 574-579 (1985).
41. J. W. Beetsch, T. S. Park, L. L. Dugan, et al., Xanthine oxidase-derived superoxide causes reoxygenation injury of ischemic cerebral endothelial cells, Brain Res. 786(1-2), 89-95 (1998).
42. A. Sermet, N. Tasdemir, B. Deniz, et al., Time-dependent changes in superoxide dismutase, catalase, xanthine dehydrogenase and oxidase activities in focal cerebral ischaemia, Cytobios 102(401), 157-172 (2000).
43. J. P. Broderick, Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality, Stroke 247, 987-993 (1993).